By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PhaseBio Pharmaceuticals, Inc. 

4020 Aerial Center Parkway
Suite 101
Morrisville  North Carolina  27560  U.S.A.
Phone: 919-535-8861 Fax: 919-535-8867


Start Up

Company News
PhaseBio Announces Leadership Team Appointments 4/7/2016 10:52:02 AM
PhaseBio Receives FDA Orphan Drug Designation For Vasomera (PB1046) For The Treatment Of Cardiomyopathy Associated With Dystrophinopathies 12/1/2015 7:28:27 AM
PhaseBio Announces Initiation Of Phase IIa Multiple Ascending Dose Study Of Once-Weekly Basal Insulin PE0139 In Type 2 Diabetes 11/9/2015 7:46:33 AM
PhaseBio To Present At Rodman & Renshaw 17th Annual Global Investment Conference 9/3/2015 7:21:57 AM
PhaseBio Announces Positive Data For Type 2 Diabetes Treatments PE0139 And PB1023 6/8/2015 7:32:30 AM
PhaseBio To Present At The American Diabetes Association 75th Scientific Sessions 6/2/2015 7:30:38 AM
PhaseBio Announces Promising Pre-Clinical Results For PB1046 In Models Of Duchenne Muscular Dystrophy 4/22/2015 7:50:43 AM
AstraZeneca PLC (AZN)-Backed PhaseBio Locks in $40 Million 3/12/2015 5:56:29 AM
PhaseBio Pharmaceuticals, Inc. Announces Expansion Of Leadership Team 3/3/2015 7:48:08 AM
PhaseBio Pharmaceuticals, Inc. Expands Clinical Development of Vasomera, an Investigational Treatment for Cardiopulmonary Diseases 6/18/2013 9:30:58 AM